Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,667 | -2,411 | -5 | N/A | -2,553 |
| Depreciation Amortization | 709 | 425 | 0 | N/A | 776 |
| Accounts receivable | -85 | -106 | 205 | N/A | -198 |
| Accounts payable and accrued liabilities | N/A | N/A | 4 | N/A | N/A |
| Other Working Capital | 981 | 251 | 4 | N/A | 200 |
| Other Operating Activity | 1,273 | 755 | -209 | 0 | 1,007 |
| Operating Cash Flow | $-1,789 | $-1,087 | $-2 | $N/A | $-769 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | N/A | -58 | N/A | -6 |
| Investing Cash Flow | $-8 | $N/A | $-58 | $N/A | $-6 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 800 | N/A | 800 |
| Debt Issued | N/A | N/A | 270 | N/A | 270 |
| Debt Repayment | -466 | -328 | -233 | N/A | -52 |
| Common Stock Issued | 2,217 | 2,217 | 6 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -837 | 0 | 0 |
| Financing Cash Flow | $1,752 | $1,889 | $6 | $N/A | $1,018 |
| Beginning Cash Position | 139 | 139 | 2 | N/A | 201 |
| End Cash Position | 95 | 942 | 6 | N/A | 445 |
| Net Cash Flow | $-45 | $803 | $4 | $N/A | $244 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,789 | -1,087 | -2 | N/A | -769 |
| Capital Expenditure | -8 | N/A | -58 | N/A | -6 |
| Free Cash Flow | -1,797 | -1,087 | -60 | 0 | -774 |